Raptiva
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Unlike Tysabri, which reemerged from a PML scare with a risk mitigation program, Raptiva won't return to the U.S. market, sources…
La Agencia Espanola de Medicamentos y Productos Sanitarios (AEMPS) informa a los
profesionales sanitarios de la suspension de…
Tumor necreosis factor alfa (TNF-a) - hemmere, og andre biologiske inflammatoriske modifiserende legemidler blir brukt innen…
Raptiva's exit leaves some patients without a treatment that had been working for them, dermatologists say. It also heightens…
A szerzôk egy 61 éves férfi beteg esetét ismertetik, aki súlyos terápia rezisztens psoriasis vulgarisban szenved. Éveken kereszt…
Winston-Salem, N.C. - Even before lesions begin to improve, patients with moderate to severe plaque psoriasis feel better a few…